183 related articles for article (PubMed ID: 11422259)
1. Linezolid breakpoints.
European Committee on Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
Clin Microbiol Infect; 2001 May; 7(5):283-4. PubMed ID: 11422259
[No Abstract] [Full Text] [Related]
2. Preface. The evidence for the clinical role of linezolid beyond its licence.
Koerner R; Hope R
J Antimicrob Chemother; 2011 May; 66 Suppl 4():iv1. PubMed ID: 21553405
[No Abstract] [Full Text] [Related]
3. [Linezolid (Zyvox)--a novel antibacterial agent for treatments of multidrug-resistant infections].
Blatun LA
Antibiot Khimioter; 2002; 47(2):38-46. PubMed ID: 12087723
[No Abstract] [Full Text] [Related]
4. Emergence of linezolid-resistant Enterococcus faecium during treatment of enterococcal infections.
Bassetti M; Farrel PA; Callan DA; Topal JE; Dembry LM
Int J Antimicrob Agents; 2003 Jun; 21(6):593-4. PubMed ID: 12791477
[No Abstract] [Full Text] [Related]
5. Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection.
Seedat J; Zick G; Klare I; Konstabel C; Weiler N; Sahly H
Antimicrob Agents Chemother; 2006 Dec; 50(12):4217-9. PubMed ID: 16982791
[TBL] [Abstract][Full Text] [Related]
6. [Linezolid (Zivox), a new highly efficient antibiotic for therapy of Gram-positive infections].
Rebenok ZhA
Antibiot Khimioter; 2004; 49(2):26-8. PubMed ID: 15285410
[No Abstract] [Full Text] [Related]
7. Therapeutic challenges in the era of antibiotic resistance.
Lee C
Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S197-9. PubMed ID: 19134519
[TBL] [Abstract][Full Text] [Related]
8. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid.
Gonzales RD; Schreckenberger PC; Graham MB; Kelkar S; DenBesten K; Quinn JP
Lancet; 2001 Apr; 357(9263):1179. PubMed ID: 11323048
[TBL] [Abstract][Full Text] [Related]
9. Preserving the effectiveness of antibiotics.
Gaynes RP
JAMA; 2010 Jun; 303(22):2293-4. PubMed ID: 20530785
[No Abstract] [Full Text] [Related]
10. Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid.
Hachem R; Afif C; Gokaslan Z; Raad I
Eur J Clin Microbiol Infect Dis; 2001 Jun; 20(6):432-4. PubMed ID: 11476449
[No Abstract] [Full Text] [Related]
11. Linezolid resistance in a clinical isolate of Staphylococcus aureus.
Tsiodras S; Gold HS; Sakoulas G; Eliopoulos GM; Wennersten C; Venkataraman L; Moellering RC; Ferraro MJ
Lancet; 2001 Jul; 358(9277):207-8. PubMed ID: 11476839
[TBL] [Abstract][Full Text] [Related]
12. Relationship of linezolid minimum inhibitory concentration and time to bacterial eradication in treatment for methicillin-resistant Staphylococcus aureus infection.
Moise PA; Castro RS; Sul C; Forrest A; Sakoulas G
Ann Pharmacother; 2008 Apr; 42(4):592-3. PubMed ID: 18349303
[No Abstract] [Full Text] [Related]
13. Antimicrobial activity of linezolid against Gram-positive cocci isolated in Brazil.
Sader HS; Gales AC; Jones RN
Braz J Infect Dis; 2001 Aug; 5(4):171-6. PubMed ID: 11712961
[TBL] [Abstract][Full Text] [Related]
14. [Role of linezolid in antimicrobial therapy].
Carmona PM; Romá E; Monte E; García J; Gobernado M
Enferm Infecc Microbiol Clin; 2003 Jan; 21(1):30-41. PubMed ID: 12550042
[TBL] [Abstract][Full Text] [Related]
15. Resistance to linezolid. Are we surprised? How hard should we look?
Lomaestro BM
Ann Pharmacother; 2003 Jun; 37(6):909-11. PubMed ID: 12773084
[No Abstract] [Full Text] [Related]
16. In vitro and in vivo activities of LCB01-0371, a new oxazolidinone.
Jeong JW; Jung SJ; Lee HH; Kim YZ; Park TK; Cho YL; Chae SE; Baek SY; Woo SH; Lee HS; Kwak JH
Antimicrob Agents Chemother; 2010 Dec; 54(12):5359-62. PubMed ID: 20855730
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of linezolid-resistant Staphylococcus aureus infections.
Peeters MJ; Sarria JC
Am J Med Sci; 2005 Aug; 330(2):102-4. PubMed ID: 16103790
[TBL] [Abstract][Full Text] [Related]
18. Have the oxazolidinones lived up to their billing? Future perspectives for this antibacterial class.
Nilius AM
Curr Opin Investig Drugs; 2003 Feb; 4(2):149-55. PubMed ID: 12669374
[TBL] [Abstract][Full Text] [Related]
19. [Antimicrobial and clinical effect of linezolid (ZYVOX), new class of synthetic antibacterial drug].
Irinoda K; Nomura S; Hashimoto M
Nihon Yakurigaku Zasshi; 2002 Oct; 120(4):245-52. PubMed ID: 12425150
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility testing with linezolid by different methods, in relation to published 'general breakpoints'.
Livermore DM; Mushtaq S; Warner M
J Antimicrob Chemother; 2001 Sep; 48(3):452-4. PubMed ID: 11533020
[No Abstract] [Full Text] [Related]
[Next] [New Search]
